Literature DB >> 9361296

Insulin-like growth factors regulate neuronal differentiation and survival.

E L Feldman1, K A Sullivan, B Kim, J W Russell.   

Abstract

Insulin-like growth factor I (IGF-I) and IGF-II are potent trophic factors for motor and sensory neurons and glial cells. The actions of IGF-I and IGF-II are mediated via the IGF-I receptor (IGF-IR). IGF:IGF-IR binding activates distinct signaling cascades, which in turn mediate the trophic effects of the IGFs. We discuss three main IGF coupled events: growth cone motility, long-term neurite outgrowth, and neuroprotection. Our data suggest that IGF-I enhances growth cone motility by promoting reorganization of actin and activation of focal adhesion proteins via the phosphatidylinositol-3 kinase (Pl-3K) pathway. Long-term treatment with IGF-I activates the mitogen-activated protein (MAP) kinase cascade and promotes neurite outgrowth. A separable, but likely linked, action of the IGFs via Pl-3K is protection of neurons from apoptosis. These pleotrophic effects of IGFs suggest that this family of growth factors may have potential clinical utility in the treatment of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361296     DOI: 10.1006/nbdi.1997.0156

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  40 in total

1.  Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB.

Authors:  C Meier; E Parmantier; A Brennan; R Mirsky; K R Jessen
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

2.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

Review 3.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

Review 4.  The insulin-like growth factor system and the fetal brain: effects of poor maternal nutrition.

Authors:  Thomas J McDonald; Mark J Nijland; Peter W Nathanielsz
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

Review 5.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

6.  Genes and outcome after aneurysmal subarachnoid haemorrhage.

Authors:  Y M Ruigrok; A J C Slooter; A Bardoel; C J M Frijns; G J E Rinkel; C Wijmenga
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

7.  RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.

Authors:  Ulrich Hermanto; Cong S Zong; Weiqun Li; Lu-Hai Wang
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts.

Authors:  Deirdre A Buckley; Alan Cheng; Patrick A Kiely; Michel L Tremblay; Rosemary O'Connor
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 9.  Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS.

Authors:  Daniel Chesik; Jacques De Keyser; Nadine Wilczak
Journal:  J Mol Neurosci       Date:  2008-02-26       Impact factor: 3.444

10.  A novel combination of factors, termed SPIE, which promotes dopaminergic neuron differentiation from human embryonic stem cells.

Authors:  Tandis Vazin; Kevin G Becker; Jia Chen; Charles E Spivak; Carl R Lupica; Yongqing Zhang; Lila Worden; William J Freed
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.